Millennium Management Portfolio holdings
Millennium Management is a multistrategy hedge fund firm, started in 1989 by Israel Englander along with Ronald Shear, an acquaintance from the American Stock Exchange who left after six months. Englander remains its principal. It works as a platform: many separate investment teams, each with a portfolio manager given money to trade in a variety of strategies. Its teams research and pick individual companies, run computer-driven strategies, and trade fixed income, commodities and credit. In 2018 it launched a joint venture with WorldQuant, a computer-driven investment firm. Its clients include state and local government bodies and sovereign wealth funds.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.07B |
| 2 |
SpaceX
SPCX
|
+$2.99B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$1.11B |
| 4 |
Microsoft
MSFT
|
+$584M |
| 5 |
Bloom Energy
BE
|
+$547M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.65B |
| 2 |
Marvell Technology
MRVL
|
+$1.16B |
| 3 |
Apple
AAPL
|
+$1.12B |
| 4 |
Sandisk
SNDK
|
+$1.11B |
| 5 |
Micron Technology
MU
|
+$816M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.34% |
| 2 | Technology | 9.51% |
| 3 | Industrials | 7.56% |
| 4 | Financials | 5.78% |
| 5 | Healthcare | 5.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2076
BrightSpire Capital
BRSP
$458M
| $11.4M | ﹤0.01% |
2,088,436
+921,492
| +79% | +$5.28M |
2021 Q2
20 quarters
|
|
2077
CALL
Incyte
INCY
$25B
| $11.4M | ﹤0.01% |
+100,400
| New | +$10M |
2026 Q2
0 quarters
|
|
2078
Immunic
IMUX
$108M
| $11.4M | ﹤0.01% |
740,347
+362,355
| +96% | +$4.47M |
2024 Q1
9 quarters
|
|
2079
Evertec
EVTC
$2.08B
| $11.4M | ﹤0.01% |
409,440
-194,521
| -32% | -$5.17M |
2022 Q2
16 quarters
|
|
2080
United Natural Foods
UNFI
$2.91B
| $11.4M | ﹤0.01% |
248,990
-157,054
| -39% | -$7.78M |
2022 Q2
16 quarters
|
|
2081
PUT
Truist Financial
TFC
$61B
| $11.4M | ﹤0.01% |
228,200
+84,300
| +59% | +$4.15M |
2019 Q4
26 quarters
|
|
2082
PUT
Unilever
UL
$144B
| $11.4M | ﹤0.01% |
189,100
+109,200
| +137% | +$6.31M |
2025 Q1
5 quarters
|
|
2083
PUT
Stryker
SYK
$130B
| $11.4M | ﹤0.01% |
36,100
-19,600
| -35% | -$6.18M |
2020 Q4
22 quarters
|
|
2084
AXIS Capital
AXS
$7.73B
| $11.4M | ﹤0.01% |
105,784
-301,131
| -74% | -$30.2M |
2016 Q3
39 quarters
|
|
2085
Averin Capital Acquisition Corp
ACAA
$359M
| $11.4M | ﹤0.01% |
+1,141,000
| New | +$11.3M |
2026 Q2
0 quarters
|
|
2086
CALL
Fair Isaac
FICO
$15.1B
| $11.4M | ﹤0.01% |
9,500
-1,500
| -14% | -$1.68M |
2025 Q1
5 quarters
|
|
2087
PUT
Union Pacific
UNP
$183B
| $11.3M | ﹤0.01% |
41,700
-108,000
| -72% | -$28.4M |
2019 Q4
26 quarters
|
|
2088
Home BancShares
HOMB
$6.07B
| $11.3M | ﹤0.01% |
+396,846
| New | +$10.8M |
2026 Q2
0 quarters
|
|
2089
Arcos Dorados Holdings
ARCO
$1.49B
| $11.3M | ﹤0.01% |
1,405,483
+1,267,974
| +922% | +$11M |
2015 Q4
42 quarters
|
|
2090
CALL
CSX Corp
CSX
$96.4B
| $11.3M | ﹤0.01% |
237,800
-67,800
| -22% | -$3.06M |
2019 Q1
29 quarters
|
|
2091
SpyGlass Pharma
SGP
$1.15B
| $11.3M | ﹤0.01% |
507,257
+38,463
| +8% | +$834K |
2026 Q1
1 quarter
|
|
2092
Aura Minerals Inc
AUGO
$6.07B
| $11.3M | ﹤0.01% |
179,343
-597,403
| -77% | -$47.1M |
2025 Q3
3 quarters
|
|
2093
PUT
Wingstop
WING
$4.53B
| $11.3M | ﹤0.01% |
65,000
-4,100
| -6% | -$646K |
2024 Q3
7 quarters
|
|
2094
Candel Therapeutics
CADL
$692M
| $11.3M | ﹤0.01% |
1,093,905
+33,819
| +3% | +$255K |
2026 Q1
1 quarter
|
|
2095
Mirum Pharmaceuticals
MIRM
$6.3B
| $11.3M | ﹤0.01% |
96,213
-272,362
| -74% | -$27.3M |
2023 Q3
11 quarters
|
|
2096
CALL
Sprouts Farmers Market
SFM
$5.02B
| $11.3M | ﹤0.01% |
133,100
+60,700
| +84% | +$4.91M |
2025 Q4
2 quarters
|
|
2097
Littelfuse
LFUS
$9.8B
| $11.2M | ﹤0.01% |
24,692
-88,099
| -78% | -$38.1M |
2024 Q1
9 quarters
|
|
2098
American Battery Technology Co
ABAT
$184M
| $11.2M | ﹤0.01% |
3,967,892
-459,448
| -10% | -$1.47M |
2025 Q2
4 quarters
|
|
2099
AN2 Therapeutics
ANTX
$160M
| $11.2M | ﹤0.01% |
2,318,692
+96,190
| +4% | +$414K |
2025 Q4
2 quarters
|
|
2100
Optimum Communications Inc
OPTU
$263M
| $11.2M | ﹤0.01% |
7,723,322
-1,800,343
| -19% | -$2.24M |
2018 Q1
33 quarters
|
|
Similar funds
Millennium Management's Q2 2026 Portfolio in Review
As of Q2 2026, Millennium Management held 6,628 positions worth $276B, up 15% from $240B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management's Q2 2026 filing shows 986 new, 2,006 increased, 2,341 reduced and 833 closed positions. Its largest new stake was SpaceX: 17,604,863 shares worth $2.98B. The largest sale was State Street SPDR Portfolio S&P 500 ETF, an estimated $1.65B.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, up from 54% a quarter earlier, followed by Technology and Industrials.
- Millennium Management's largest Q2 2026 buy was SpaceX: 17,604,863 shares worth $2.98B.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $3.07B increase.
- Millennium Management's biggest Q2 2026 reduction was Marvell Technology, cutting an estimated $1.16B.
- Millennium Management fully exited State Street SPDR Portfolio S&P 500 ETF in Q2 2026, selling an estimated $1.65B.
- Millennium Management's ten largest holdings make up 18% of its $276B portfolio in Q2 2026.
- Millennium Management opened 986 new positions and closed 833 in Q2 2026.
- Millennium Management's portfolio value rose 15% quarter-over-quarter to $276B.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.